Risk factors and immunomodulators use in steroid-refractory checkpoint inhibitor pneumonitis

BACKGROUND: Checkpoint inhibitor pneumonitis (CIP) that does not respond to corticosteroids is termed steroid-refractory CIP. We aimed to find risk factors of steroid-refractory CIP and evaluate the management strategies of immunomodulators (IMs). METHODS: Patients with CIP were identified between A...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanlin, Jia, Xiaohui, Zhang, Yajuan, Du, Yonghao, Chang, Yuzhu, Shen, Yuan, Mao, Ziyang, Liu, Mengjie, Sun, Hong, Guo, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254972/
https://www.ncbi.nlm.nih.gov/pubmed/37290926
http://dx.doi.org/10.1136/jitc-2023-006982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254972/
https://www.ncbi.nlm.nih.gov/pubmed/37290926
http://dx.doi.org/10.1136/jitc-2023-006982

Ejemplares similares